HEAD Injury Serum Markers and Multi-modalities for Assessing Response to Trauma
Public ClinicalTrials.gov record NCT04423198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
HEAD Injury Serum Markers and Multi-modalities for Assessing Response to Trauma II
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of HeadSMART II (HEAD injury Serum markers and Multi-modalities for Assessing Response to Trauma II) is to develop an In-Vitro Diagnostic, the BRAINBox TBI test, to aid in the diagnosis and prognosis of patients with mild traumatic brain injury, by incorporating blood biomarkers, clinical assessments, and tools to measure associated neurocognitive impairments.
Study identification
- NCT ID
- NCT04423198
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 2,000 participants
Conditions and interventions
Conditions
Interventions
- Cognitive Assessment Behavioral
- Patient Reported Neurological Outcome Assessments Behavioral
- Blood Draw Procedure
Behavioral · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 30, 2020
- Primary completion
- Nov 30, 2021
- Completion
- Nov 30, 2021
- Last update posted
- Aug 3, 2021
2020 – 2021
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | Recruiting |
| Detroit Receiving | Detroit | Michigan | 48201 | Recruiting |
| Harper University Hospital | Detroit | Michigan | 48201 | Recruiting |
| Sinai Grace Hospital | Detroit | Michigan | 48235 | Recruiting |
| University of Rochester Medical Center | Rochester | New York | 14620 | Recruiting |
| Stony Brook Medicine | Stony Brook | New York | 11794 | Recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
| John Peter Smith (JPS) Health Network | Fort Worth | Texas | 76104 | Recruiting |
| Baylor College of Medicine/Ben Taub | Houston | Texas | 77030 | Recruiting |
| Baylor College of Medicine/St. Luke's Medical Center | Houston | Texas | 77030 | Recruiting |
| Carilion Clinic | Roanoke | Virginia | 24014 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04423198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2021 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04423198 live on ClinicalTrials.gov.